1. Humbert M, Sitbon O, Simonneau G: Treatment of pulmonary arterial hypertension. N Engl J Med 2004, 351(14):1425-1436.
2. Chan SY, Loscalzo J: Pathogenic mechanisms of pulmonary arterial hypertension. J Mol Cell Cardiol 2008, 44(1):14-30.
3. Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, Langleben D, Manes A, Satoh T, Torres F et al: [Definitions and diagnosis of pulmonary hypertension]. Turk Kardiyol Dern Ars 2014, 42 Suppl 1:55-66.
4. Rubin LJ: Primary pulmonary hypertension. N Engl J Med 1997, 336(2):111-117.
5. Zhang CY, Liu M, Wan JM, Gao MQ, Zhang Y, Soyan M, Wang HL, Bai Y: Role of Noncoding RNA in Pulmonary Arterial Hypertension and Potential Drug Therapeutic Target. Curr Top Med Chem 2018, 18(12):975-986.
6. Lee A, McLean D, Choi J, Kang H, Chang W, Kim J: Therapeutic implications of microRNAs in pulmonary arterial hypertension. BMB Rep 2014, 47(6):311-317.
7. Liu Y, Sun Z, Zhu J, Xiao B, Dong J, Li X: LncRNA-TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism. J Cell Physiol 2018, 233(6):4801-4814.
8. Chen J, Guo J, Cui X, Dai Y, Tang Z, Qu J, Raj JU, Hu Q, Gou D: The Long Noncoding RNA LnRPT Is Regulated by PDGF-BB and Modulates the Proliferation of Pulmonary Artery Smooth Muscle Cells. Am J Respir Cell Mol Biol 2018, 58(2):181-193.
9. Shang D, Yang H, Xu Y, Yao Q, Zhou W, Shi X, Han J, Su F, Su B, Zhang C et al: A global view of network of lncRNAs and their binding proteins. Mol Biosyst 2015, 11(2):656-663.
10. Teimuri S, Hosseini A, Rezaenasab A, Ghaedi K, Ghoveud E, Etemadifar M, Nasr-Esfahani MH, Megraw TL: Integrative Analysis of lncRNAs in Th17 Cell Lineage to Discover New Potential Biomarkers and Therapeutic Targets in Autoimmune Diseases. Mol Ther Nucleic Acids 2018, 12:393-404.
11. Jae N, Heumuller AW, Fouani Y, Dimmeler S: Long non-coding RNAs in vascular biology and disease. Vascul Pharmacol 2019, 114:13-22.
12. Bink DI, Lozano-Vidal N, Boon RA: Long Non-Coding RNA in Vascular Disease and Aging. Noncoding RNA 2019, 5(1).
13. Cao Y, Yang Y, Wang L, Li L, Zhang J, Gao X, Dai S, Zhang Y, Guo Q, Peng YG et al: Analyses of long non-coding RNA and mRNA profiles in right ventricle myocardium of acute right heart failure in pulmonary arterial hypertension rats. Biomed Pharmacother 2018, 106:1108-1115.
14. Su H, Xu X, Yan C, Shi Y, Hu Y, Dong L, Ying S, Ying K, Zhang R: LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT1R via sponging let-7b in monocrotaline-induced pulmonary arterial hypertension. Respir Res 2018, 19(1):254.
15. Guttman M, Garber M, Levin JZ, Donaghey J, Robinson J, Adiconis X, Fan L, Koziol MJ, Gnirke A, Nusbaum C et al: Ab initio reconstruction of cell type-specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs. Nat Biotechnol 2010, 28(5):503-510.
16. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, Rinn JL: Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 2011, 25(18):1915-1927.
17. Zhang J, Feng C, Song C, Ai B, Bai X, Liu Y, Li X, Zhao J, Shi S, Chen X et al: Identification and analysis of a key long non-coding RNAs (lncRNAs)-associated module reveal functional lncRNAs in cardiac hypertrophy. J Cell Mol Med 2018, 22(2):892-903.
18. Mercer TR, Dinger ME, Sunkin SM, Mehler MF, Mattick JS: Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci U S A 2008, 105(2):716-721.
19. Pang KC, Dinger ME, Mercer TR, Malquori L, Grimmond SM, Chen W, Mattick JS: Genome-wide identification of long noncoding RNAs in CD8+ T cells. J Immunol 2009, 182(12):7738-7748.
20. Liao Q, Liu C, Yuan X, Kang S, Miao R, Xiao H, Zhao G, Luo H, Bu D, Zhao H et al: Large-scale prediction of long non-coding RNA functions in a coding-non-coding gene co-expression network. Nucleic Acids Res 2011, 39(9):3864-3878.
21. Machado BH, Zoccal DB, Moraes DJA: Neurogenic hypertension and the secrets of respiration. Am J Physiol Regul Integr Comp Physiol 2017, 312(6):R864-R872.
22. Weir EK, Obreztchikova M, Vargese A, Cabrera JA, Peterson DA, Hong Z: Mechanisms of oxygen sensing: a key to therapy of pulmonary hypertension and patent ductus arteriosus. Br J Pharmacol 2008, 155(3):300-307.
23. Younes MN, Kim S, Yigitbasi OG, Mandal M, Jasser SA, Dakak Yazici Y, Schiff BA, El-Naggar A, Bekele BN, Mills GB et al: Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer. Mol Cancer Ther 2005, 4(8):1146-1156.
24. Wiseman SM, Masoudi H, Niblock P, Turbin D, Rajput A, Hay J, Bugis S, Filipenko D, Huntsman D, Gilks B: Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment. Ann Surg Oncol 2007, 14(2):719-729.
25. Perissi V, Scafoglio C, Zhang J, Ohgi KA, Rose DW, Glass CK, Rosenfeld MG: TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR/SMRT transcriptional repression checkpoints. Mol Cell 2008, 29(6):755-766.
26. Li JY, Daniels G, Wang J, Zhang X: TBL1XR1 in physiological and pathological states. Am J Clin Exp Urol 2015, 3(1):13-23.
27. Marvisi M, Zambrelli P, Brianti M, Civardi G, Lampugnani R, Delsignore R: Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy. Eur J Intern Med 2006, 17(4):267-271.
28. Chu JW, Kao PN, Faul JL, Doyle RL: High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension. Chest 2002, 122(5):1668-1673.
29. Silva DR, Gazzana MB, John AB, Siqueira DR, Maia AL, Barreto SS: Pulmonary arterial hypertension and thyroid disease. J Bras Pneumol 2009, 35(2):179-185.
30. Li Y, Kim JG, Kim HJ, Moon MY, Lee JY, Kim J, Kim SC, Song DK, Kim YS, Park JB: Small GTPases Rap1 and RhoA regulate superoxide formation by Rac1 GTPases activation during the phagocytosis of IgG-opsonized zymosans in macrophages. Free Radic Biol Med 2012, 52(9):1796-1805.
31. Chen Z, Guo L, Sprang SR, Sternweis PC: Modulation of a GEF switch: autoinhibition of the intrinsic guanine nucleotide exchange activity of p115-RhoGEF. Protein Sci 2011, 20(1):107-117.
32. Gaba SJ, Bourgouin-Karaouni D, Dujols P, Michel FB, Prefaut C: Effects of adenosine triphosphate on pulmonary circulation in chronic obstructive pulmonary disease. ATP: a pulmonary vasoregulator? Am Rev Respir Dis 1986, 134(6):1140-1144.
33. Di Virgilio F, Boeynaems JM, Robson SC: Extracellular nucleotides as negative modulators of immunity. Curr Opin Pharmacol 2009, 9(4):507-513.
34. Lommatzsch M, Cicko S, Muller T, Lucattelli M, Bratke K, Stoll P, Grimm M, Durk T, Zissel G, Ferrari D et al: Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 181(9):928-934.
35. Duan L, Hu GH, Li YJ, Zhang CL, Jiang M: P2X7 receptor is involved in lung injuries induced by ischemia-reperfusion in pulmonary arterial hypertension rats. Mol Immunol 2018, 101:409-418.
36. Zhu Y, Wu Y, Shi W, Wang J, Yan X, Wang Q, Liu Y, Yang L, Gao L, Li M: Inhibition of ubiquitin proteasome function prevents monocrotaline-induced pulmonary arterial remodeling. Life Sci 2017, 173:36-42.